Literature DB >> 15755966

What is targeted therapy?

George W Sledge.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15755966     DOI： 10.1200/JCO.2005.01.016

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  26 in total

Review 1.  Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies.

Authors:  James P B O'Connor; Alan Jackson; Geoff J M Parker; Caleb Roberts; Gordon C Jayson
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

2.  Adaptive clinical trial designs in oncology.

Authors:  Yong Zang; J Jack Lee
Journal:  Chin Clin Oncol       Date:  2014-12

3.  Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide.

Authors:  Po-Chin Liang; Hui-Ju Ch'ang; Chiun Hsu; Li-Tzong Chen; Tiffany T F Shih; Tsang Wu Liu
Journal:  Hepatol Int       Date:  2014-07-26       Impact factor: 6.047

4.  Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.

Authors:  Ya-Chen Tina Shih; Ying Xu; Lei Liu; Fabrice Smieliauskas
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

5.  Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer Therapies.

Authors:  J Barth; Christian Jackisch; Michael Untch
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

Review 6.  [Future of chemotherapy].

Authors:  M-O Grimm; F H Hartmann; R Ackermann
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

7.  Optimal marker-strategy clinical trial design to detect predictive markers for targeted therapy.

Authors:  Yong Zang; Suyu Liu; Ying Yuan
Journal:  Biostatistics       Date:  2016-03-07       Impact factor: 5.899

Review 8.  Targeted therapy in rare cancers--adopting the orphans.

Authors:  Javier Munoz; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2012-09-11       Impact factor: 66.675

9.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

Review 10.  Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review.

Authors:  Fabrice Smieliauskas; Chun-Ru Chien; Chan Shen; Daniel M Geynisman; Ya-Chen Tina Shih
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.